FDA.reportPublic FDA data

varenicline 0.03 MG/ACTUAT Nasal Spray [Tyrvaya]

RxCUI
2572371
RxNorm name
varenicline 0.03 MG/ACTUAT Nasal Spray [Tyrvaya]
Display name
varenicline 0.03 MG/ACTUAT Nasal Spray [Tyrvaya]
Full name
varenicline 0.03 MG/ACTUAT Nasal Spray [Tyrvaya]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
014c93dc-5737-479c-a9f0-aaadac1ac298tyrvaya 0.03 MG/ACTUAT Nasal Spray [PSN] · varenicline 0.03 MG/ACTUAT Nasal Spray [Tyrvaya] [SBD] · Tyrvaya 0.03 MG per 0.05 ML Nasal Spray [SY] · Tyrvaya 0.03 MG/ACTUAT Nasal Spray [SY]414These highlights do not include all the information needed to use TYRVAYA safely and effectively. See full prescribing information for TYRVAYA. TYRVAYA ® (varenicline solution) nasal spray Initial U.S. Approval: 200620240212